Voigtlander Christian B. 4
4 · ICU MEDICAL INC/DE · Filed Mar 9, 2026
Research Summary
AI-generated summary of this filing
ICU Medical (ICUI) COO Christian Voigtlander Receives 75,279 Shares
What Happened
Christian B. Voigtlander, Chief Operating Officer of ICU Medical (ICUI), received a total of 75,279 shares on March 7–8, 2026 upon settlement/conversion of restricted and performance-based restricted stock units (RSUs/PRSUs). To satisfy tax withholding obligations, 41,613 of those shares were disposed/withheld at $132.00 per share, generating proceeds of $5,492,916 (1,946 shares -> $256,872 on 3/7; 39,667 shares -> $5,236,044 on 3/8). Net new shares retained by Voigtlander after withholding: 33,666.
Key Details
- Transaction dates: March 7–8, 2026; Form 4 filed March 9, 2026 (within the typical 2-business-day reporting window).
- Exercise/conversion code M: 3,522 shares (3/7) and 71,757 shares (3/8) reported as acquired (RSU/PRSU settlement); no purchase/exercise price (F3, F7).
- Withholding/tax payment code F: 1,946 shares (3/7) and 39,667 shares (3/8) sold/forfeited at $132.00 to cover taxes; total proceeds $5,492,916.
- Footnotes: PRSUs granted 3/8/2024 were certified on 2/11/2026 and earned at 250% of target (F2, F6); some awards vest over multi-year schedules (F4, F5).
- Net effect: +33,666 shares to Voigtlander’s holdings after tax withholding.
Context
- These transactions reflect settlement of compensation awards (RSUs/PRSUs), not an open‑market purchase for investment. The disposals were to cover tax liabilities (commonly done via share withholding or broker sale) rather than a market-driven sale.
- M = conversion/exercise of derivative (here, conversion of units into shares); F = payment of exercise price or tax liability.
- This is routine compensation settlement activity; it does not by itself indicate the insider’s view on the company’s stock price.
Insider Transaction Report
Form 4
Voigtlander Christian B.
Chief Operating Officer
Transactions
- Exercise/Conversion
Common Stock
[F1]2026-03-07+3,522→ 9,610 total - Tax Payment
Common Stock
2026-03-07$132.00/sh−1,946$256,872→ 7,664 total - Exercise/Conversion
Common Stock
[F2]2026-03-08+71,757→ 79,421 total - Tax Payment
Common Stock
2026-03-08$132.00/sh−39,667$5,236,044→ 39,754 total - Exercise/Conversion
Common Stock
[F1][F3][F4][F5]2026-03-07−3,522→ 7,044 totalFrom: 2026-03-07→ Common Stock (3,522 underlying) - Exercise/Conversion
Performance Shares
[F6][F7][F2]2026-03-08−71,757→ 0 totalExercise: $0.00From: 2026-03-08Exp: 2026-03-08→ Common Stock (71,757 underlying)
Footnotes (7)
- [F1]These securities are Restricted Stock Units.
- [F2]Represents the settlement of performance stock units granted on 3/8/2024. Upon the certification of performance results by the Compensation Committee on 2/11/26, the PRSUs were earned at 250% of target, resulting in the acquisition of the shares reported herein.
- [F3]There is neither a purchase price nor an exercise price for the Restricted Stock Units.
- [F4]One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date.
- [F5]These are restricted stock units that fully vest 3 years from the grant date.
- [F6]These Securities are Performance-based Restricted Stock Units (PRSU).
- [F7]There is neither a purchase price nor an exercise price for the PRSUs.
Signature
By: Paula Darbyshire, Attorney-in-Fact For: Christian Voigtlander|2026-03-09